Low-Molecular-Weight Heparin and Other Antithrombotic Agents in the Setting of a Primarily Medical Treatment of Unstable Coronary Artery Disease

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 30, Iss. 2, 2004-11 ,pp. : 122-127

Karger

Access to resources Recommend Favorite

Low-Molecular-Weight Heparin and Other Antithrombotic Agents in the Setting of a Fast-Track Revascularization in Unstable Coronary Artery Disease

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 30, Iss. 2, 2004-11 ,pp. : 114-121

Karger

Access to resources Recommend Favorite

Secondary Prevention of Venous Thromboembolism: A Role for Low-Molecular-Weight Heparin

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 28, Iss. 5, 1999-07 ,pp. : 236-243

Karger

Access to resources Recommend Favorite

Antithrombotic drugs in acutely ill medical patients: review and meta-analysis of interventional trials with low-molecular-weight heparin and fondaparinux

By Loffredo Lorenzo   Perri Ludovica   Catasca Elisa   Del Ben Maria   Angelico Francesco   Violi Francesco  

Clinical Practice, Vol. 10, Iss. 5, 2013-09 ,pp. : 615-627

Future Medicine

Access to resources Recommend Favorite

Dalteparin, a Low-Molecular-Weight Heparin, Reduces Ischaemia/Reperfusion-Induced Liver Injury in Rats by Increasing the Hepatic Level of Prostacyclin

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 30, Iss. 2, 2004-11 ,pp. : 170-171

Karger

Access to resources Recommend Favorite